This intricate interplay underscores the pivotal roles of ICAM-1 and VCAM-1 in cardiovascular pathophysiology and accentuates their potential as therapeutic targets for mitigating cardiovascular disease progression, particularly through the modulation of NF-kB signaling [46]. The gene discussed is NFKB1; the disease is cardiovascular disorder.